Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TORCH: SOX (TS-1 + Oxaliplatin) in Metastatic Breast Cancer
NCT00527930Phase 2Completed
- Sponsor
- Seoul National University Hospital
- Start
- Sep 2007
- Primary completion
- Oct 2013
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin, tegafur in breast cancer, sponsored by Seoul National University Hospital. Started Sep 2007; status: completed.
02
Drugs
oxaliplatintegafur
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00527930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00527930.